These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21845086)

  • 1. Isoniazid proliposome powders for inhalation-preparation, characterization and cell culture studies.
    Rojanarat W; Changsan N; Tawithong E; Pinsuwan S; Chan HK; Srichana T
    Int J Mol Sci; 2011; 12(7):4414-34. PubMed ID: 21845086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled pyrazinamide proliposome for targeting alveolar macrophages.
    Rojanarat W; Nakpheng T; Thawithong E; Yanyium N; Srichana T
    Drug Deliv; 2012; 19(7):334-45. PubMed ID: 22985352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A facile one-step jet-milling approach for the preparation of proliposomal dry powder for inhalation as effective delivery system for anti-TB therapeutics.
    Srichana T; Eze FN; Thawithong E
    Drug Dev Ind Pharm; 2022 Oct; 48(10):528-538. PubMed ID: 36214588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levofloxacin-proliposomes: opportunities for use in lung tuberculosis.
    Rojanarat W; Nakpheng T; Thawithong E; Yanyium N; Srichana T
    Pharmaceutics; 2012 Aug; 4(3):385-412. PubMed ID: 24300299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring safety of liposomes containing rifampicin on respiratory cell lines and in vitro efficacy against Mycobacterium bovis in alveolar macrophages.
    Changsan N; Nilkaeo A; Pungrassami P; Srichana T
    J Drug Target; 2009 Dec; 17(10):751-62. PubMed ID: 19863196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
    Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H
    J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry powder inhalation formulation of chitosan nanoparticles for co-administration of isoniazid and pyrazinamide.
    Changsan N; Sinsuebpol C
    Pharm Dev Technol; 2021 Feb; 26(2):181-192. PubMed ID: 33213232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled microparticles of antitubercular antibiotic for in vitro and in vivo alveolar macrophage targeting and activation of phagocytosis.
    Parikh R; Dalwadi S; Aboti P; Patel L
    J Antibiot (Tokyo); 2014 May; 67(5):387-94. PubMed ID: 24569669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spray-Dried Proliposome Microparticles for High-Performance Aerosol Delivery Using a Monodose Powder Inhaler.
    Omer HK; Hussein NR; Ferraz A; Najlah M; Ahmed W; Taylor KMG; Elhissi AMA
    AAPS PharmSciTech; 2018 Jul; 19(5):2434-2448. PubMed ID: 29872976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.
    Changsan N; Chan HK; Separovic F; Srichana T
    J Pharm Sci; 2009 Feb; 98(2):628-39. PubMed ID: 18484099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliposome powders prepared using a slurry method for the generation of beclometasone dipropionate liposomes.
    Khan I; Yousaf S; Subramanian S; Korale O; Alhnan MA; Ahmed W; Taylor KM; Elhissi A
    Int J Pharm; 2015 Dec; 496(2):342-50. PubMed ID: 26456265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
    Eedara BB; Tucker IG; Das SC
    Int J Pharm; 2016 Jun; 506(1-2):174-83. PubMed ID: 27091294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis.
    Rangnekar B; Momin MAM; Eedara BB; Sinha S; Das SC
    Int J Pharm; 2019 Oct; 570():118689. PubMed ID: 31513868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.
    Fabio K; Curley K; Guarneri J; Adamo B; Laurenzi B; Grant M; Offord R; Kraft K; Leone-Bay A
    AAPS PharmSciTech; 2015 Dec; 16(6):1299-306. PubMed ID: 25776985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliposome tablets manufactured using a slurry-driven lipid-enriched powders: Development, characterization and stability evaluation.
    Khan I; Yousaf S; Subramanian S; Albed Alhnan M; Ahmed W; Elhissi A
    Int J Pharm; 2018 Mar; 538(1-2):250-262. PubMed ID: 29337185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J; Chan HK; Gengenbach T; Denman JA
    Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis.
    Momin MAM; Sinha S; Tucker IG; Das SC
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1321-1331. PubMed ID: 31014129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.